Dr. Reddy's Laboratories Files Form 6-K
Ticker: RDY · Form: 6-K · Filed: Sep 16, 2024 · CIK: 1135951
Sentiment: neutral
Topics: filing, regulatory
TL;DR
DRL filed a 6-K on 9/16/24, just confirming their info. Nothing major.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on September 16, 2024, to report information as a foreign private issuer. The filing confirms the company's name, its principal executive office address in Hyderabad, India, and its standard industrial classification as Pharmaceutical Preparations.
Why It Matters
This filing serves as a routine update for investors and regulatory bodies, confirming the company's status and basic identifying information.
Risk Assessment
Risk Level: low — This filing is a standard procedural document and does not contain new financial or operational information that would typically indicate a change in risk.
Key Players & Entities
- DR REDDYS LABORATORIES LTD (company) — Filer
- 0001575872-24-001003 (accession_number) — Filing identifier
- 20240916 (date) — Filing date
- Hyderabad, India (location) — Principal executive office
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report information as a foreign private issuer to the Securities and Exchange Commission.
When was this Form 6-K filed?
This Form 6-K was filed on September 16, 2024.
What is Dr. Reddy's Laboratories Ltd.'s Standard Industrial Classification?
Dr. Reddy's Laboratories Ltd.'s Standard Industrial Classification is Pharmaceutical Preparations [2834].
Where is Dr. Reddy's Laboratories Ltd.'s principal executive office located?
Dr. Reddy's Laboratories Ltd.'s principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
Does Dr. Reddy's Laboratories Ltd. file annual reports under Form 20-F or Form 40-F?
Dr. Reddy's Laboratories Ltd. indicates that it files annual reports under cover of Form 20-F.
Filing Stats: 402 words · 2 min read · ~1 pages · Grade level 16.8 · Accepted 2024-09-16 08:20:13
Filing Documents
- drr0670_6k.htm (6-K) — 14KB
- drr0670_ex99-1.htm (EX-99.1) — 7KB
- drr0670_ex99-1img01.jpg (GRAPHIC) — 2KB
- drr0670_ex99-1img02.jpg (GRAPHIC) — 10KB
- 0001575872-24-001003.txt ( ) — 39KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: September 16, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3